Literature DB >> 9373426

Poor memory, negative symptoms and abnormal movements in never-treated Indian patients with schizophrenia.

R G McCreadie1, S Latha, R Thara, R Padmavathi, J R Ayankaran.   

Abstract

BACKGROUND: Cognitive impairment, frequently found in patients with schizophrenia, may be associated with negative symptoms and dyskinesia. However, antipsychotic medication may be a confounding variable. These putative associations may be clarified by examining never-treated patients.
METHOD: Never-treated elderly schizophrenic patients (n = 19) living in south-east India were compared with treated patients (n = 25) and normal subjects (n = 55). Memory was assessed by the Wechsler Memory Scale, negative symptoms by the Positive and Negative Syndrome Scale, and dyskinesia by the Abnormal Involuntary Movements Scale.
RESULTS: Normal subjects had a higher mean memory quotient than patients. There were no significant differences between never-treated and treated patients. Negative symptoms were associated with a poorer memory in the never-treated group. There was no association between memory and dyskinesia.
CONCLUSIONS: There is an association in never-treated patients between a poorer memory and negative symptoms, but not between a poorer memory and dyskinesia.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9373426     DOI: 10.1192/bjp.171.4.360

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  7 in total

1.  Involuntary movements and their correlates in first-episode psychoses.

Authors:  Pallav Pareek; Tejas S Bhojraj; Debra M Montrose; Rajaprabhakaran Rajarethinam; John A Sweeney; Matcheri S Keshavan
Journal:  Acta Neuropsychiatr       Date:  2010-10       Impact factor: 3.403

2.  From Memories of Past Experiences to Present Motivation? A Meta-analysis on the Association Between Episodic Memory and Negative Symptoms in People With Psychosis.

Authors:  Matthias Pillny; Katarina Krkovic; Laura Buck; Tania M Lincoln
Journal:  Schizophr Bull       Date:  2022-03-01       Impact factor: 7.348

3.  Dyskinesia and parkinsonism in antipsychotic-naive patients with schizophrenia, first-degree relatives and healthy controls: a meta-analysis.

Authors:  Jeroen P F Koning; Diederik E Tenback; Jim van Os; André Aleman; René S Kahn; Peter N van Harten
Journal:  Schizophr Bull       Date:  2008-11-05       Impact factor: 9.306

Review 4.  Verbal declarative memory dysfunction in schizophrenia: from clinical assessment to genetics and brain mechanisms.

Authors:  Michael A Cirillo; Larry J Seidman
Journal:  Neuropsychol Rev       Date:  2003-06       Impact factor: 7.444

5.  Varenicline for cognitive impairment in people with schizophrenia: systematic review and meta-analysis.

Authors:  Timothy Tanzer; Shelukumar Shah; Catherine Benson; Veronica De Monte; Victoria Gore-Jones; Susan L Rossell; Frances Dark; Steve Kisely; Dan Siskind; Catarina Drumonde Melo
Journal:  Psychopharmacology (Berl)       Date:  2019-12-03       Impact factor: 4.530

6.  Movement disorders in neuroleptic-naïve patients with schizophrenia spectrum disorders.

Authors:  Moges Ayehu; Teshome Shibre; Barkot Milkias; Abebaw Fekadu
Journal:  BMC Psychiatry       Date:  2014-10-09       Impact factor: 3.630

7.  Localized abnormalities in the cingulum bundle in patients with schizophrenia: a Diffusion Tensor tractography study.

Authors:  Thomas J Whitford; Sun Woo Lee; Jungsu S Oh; Rodrigo de Luis-Garcia; Peter Savadjiev; Jorge L Alvarado; Carl-Fredrik Westin; Margaret Niznikiewicz; Paul G Nestor; Robert W McCarley; Marek Kubicki; Martha E Shenton
Journal:  Neuroimage Clin       Date:  2014-06-17       Impact factor: 4.881

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.